Council Members in this Study Group: 225
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Leading institutions connect with members of this Study Group through GLG
Medical Director and Vice President
ORLANDO CANCER CENTER![]()
Wayne Jenkins, MD, MPH, is Medical Director and Vice President for Medical Affairs at the MD Anderson Cancer Center Orlando (Orlando Cancer Center) and is Chief Strategy Officer for Orlando Health, a multi-hospital sytem in Central Florida. His clinical...
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Tomotherapy (ttpy) enters mainstream
July 26, 2007
Cancer Therapy Chain buying six Tomotherapy systems | news.moneycentral.msn.com
This news release is significant for analyzing market share of radiation therapy systems as it relates to Varian, Elekta and Tomotherapy
| Study Group Name | No. Members |
|---|---|
| Neurologists (US) | 1079 |
| Psychiatrists (US) | 1136 |
| Psychiatrists | 1535 |
| Neurologists | 1861 |
| Biostatisticians (US) | 254 |
| Biostatisticians | 381 |
| Ophthalmologists (US) | 1133 |
| Ophthalmologists | 1610 |